AN2 Therapeutics, Inc. (ANTX)
3.34
+0.04
(+1.21%)
USD |
NASDAQ |
Apr 08, 16:00
3.35
+0.01
(+0.30%)
After-Hours: 20:00
AN2 Therapeutics Market Cap : 120.04M for April 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Relmada Therapeutics, Inc. | 735.28M |
| ACADIA Pharmaceuticals, Inc. | 3.846B |
| Alnylam Pharmaceuticals, Inc. | 43.40B |
| Savara, Inc. | 1.216B |
| BioMarin Pharmaceutical, Inc. | 11.00B |
Market Cap Related Metrics
| Price to Book Value | 2.297 |
| Price | 3.34 |
| Earnings Yield | -34.34% |